Live feed06:05:00·1274dSECFilingvia QuantisnowOncocyte Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Costs Associated with Exit or Disposal Activities, Leadership Update, Regulation FD Disclosure, Financial Statements and ExhibitsByQuantisnow·Wall Street's wire, on your screen.OCX· Oncocyte CorporationHealth CareOriginal source
